Personal information

No personal information available

Activities

Collapse all

Works (8)

Correction: Relevance of Thymic Stromal Lymphopoietin on the Pathogenesis of Glioblastoma: Role of the Neutrophil

Cellular and Molecular Neurobiology
2024-12 | Journal article
DOI: 10.1007/s10571-024-01479-0
Contributors: Alejandra Infante Cruz; Juan Valentin Coronel; Paula Saibene Vélez; Federico Remes Lenicov; Juan Iturrizaga; Martín Abelleyro; Micaela Rosato; Carolina Maiumi Shiromizu; Marianela Candolfi; Mónica Vermeulen et al.
Source: check_circle
Crossref

Relevance of Thymic Stromal Lymphopoietin on the Pathogenesis of Glioblastoma: Role of the Neutrophil

Cellular and Molecular Neurobiology
2024-12 | Journal article
DOI: 10.1007/s10571-024-01462-9
Contributors: Alejandra Infante Cruz; Juan Valentin Coronel; Paula Saibene Vélez; Federico Remes Lenicov; Juan Iturrizaga; Martín Abelleyro; Micaela Rosato; Carolina Maiumi Shiromizu; Marianela Candolfi; Mónica Vermeulen et al.
Source: check_circle
Crossref

Potential of IDH mutations as immunotherapeutic targets in gliomas: a review and meta-analysis

Expert Opinion on Therapeutic Targets
2021-12-02 | Journal article
DOI: 10.1080/14728222.2021.2017422
Contributors: Nazareno Gonzalez; Antonela S. Asad; José Gómez Escalante; Jorge A. Peña Agudelo; Alejandro J. Nicola Candia; Matías García Fallit; Adriana Seilicovich; Marianela Candolfi
Source: check_circle
Crossref

Current Non-viral Gene Therapy Strategies for the Treatment of Glioblastoma

Current Medicinal Chemistry
2021-11-26 | Journal article
DOI: 10.2174/0929867328666210525141243
Contributors: Antonela Sofía Asad; Alejandro Javier Nicola Candia; Nazareno González; Camila Florencia Zuccato; Adriana Seilicovich; Marianela Candolfi
Source: check_circle
Crossref

The role of the prolactin receptor pathway in the pathogenesis of glioblastoma: what do we know so far?

Expert Opinion on Therapeutic Targets
2020-11-01 | Journal article
DOI: 10.1080/14728222.2020.1821187
Contributors: Antonela S Asad; Alejandro J Nicola Candia; Nazareno Gonzalez; Camila F Zuccato; Adriana Seilicovich; Marianela Candolfi
Source: check_circle
Crossref

Immunotherapy for gliomas: shedding light on progress in preclinical and clinical development

Expert Opinion on Investigational Drugs
2020-07-02 | Journal article
DOI: 10.1080/13543784.2020.1768528
Contributors: Maria B. Garcia-Fabiani; Maria Ventosa; Andrea Comba; Marianela Candolfi; Alejandro J. Nicola Candia; Mahmoud S. Alghamri; Padma Kadiyala; Stephen Carney; Syed M. Faisal; Anna Schwendeman et al.
Source: check_circle
Crossref

Prospects of biological and synthetic pharmacotherapies for glioblastoma

Expert Opinion on Biological Therapy
2020-03-03 | Journal article
DOI: 10.1080/14712598.2020.1713085
Contributors: David B. Altshuler; Padma Kadiyala; Felipe J. Nuñez; Fernando M. Nuñez; Stephen Carney; Mahmoud S. Alghamri; Maria B. Garcia-Fabiani; Antonela S. Asad; Alejandro J. Nicola Candia; Marianela Candolfi et al.
Source: check_circle
Crossref

Immunotherapy for the treatment of breast cancer

Expert Opinion on Biological Therapy
2017-07-03 | Journal article
DOI: 10.1080/14712598.2017.1324566
Contributors: Mariela A. Moreno Ayala; Maria Florencia Gottardo; Antonela S. Asad; Camila Zuccato; Alejandro Nicola; Adriana Seilicovich; Marianela Candolfi
Source: check_circle
Crossref

Peer review (1 review for 1 publication/grant)

Review activity for World journal of surgical oncology (1)
How many people are using ORCID?